Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
LHC Group is a medical care facilities business based in the US. LHC Group shares (LHCG) are listed on the NASDAQ and all prices are listed in US Dollars. LHC Group employs 30,000 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $155.05 |
|---|---|
| 52-week range | $108.42 - $216.65 |
| 50-day moving average | $163.82 |
| 200-day moving average | $145.97 |
| Wall St. target price | $173.00 |
| PE ratio | 48.1522 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $3.22 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $155.05 from 2022-07-01
| 1 week (2022-06-29) | -0.13% |
|---|---|
| 1 month (2022-06-02) | -6.67% |
| 3 months (2022-04-06) | -7.43% |
| 6 months (2022-01-04) | 12.62% |
| 1 year (2021-07-06) | -25.04% |
|---|---|
| 2 years (2020-07-06) | -13.48% |
| 3 years (2019-07-05) | 26.23% |
| 5 years (2017-07-05) | 129.06% |
Valuing LHC Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LHC Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
LHC Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 48x. In other words, LHC Group shares trade at around 48x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
LHC Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7684. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into LHC Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
LHC Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $201.9 million.
The EBITDA is a measure of a LHC Group's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.3 billion |
|---|---|
| Operating margin TTM | 7.96% |
| Gross profit TTM | $883 million |
| Return on assets TTM | 4.12% |
| Return on equity TTM | 7.64% |
| Profit margin | 4.44% |
| Book value | $51.12 |
| Market capitalisation | $4.8 billion |
TTM: trailing 12 months
We're not expecting LHC Group to pay a dividend over the next 12 months.
Over the last 12 months, LHC Group's shares have ranged in value from as little as $108.42 up to $216.65. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LHC Group's is 0.4419. This would suggest that LHC Group's shares are less volatile than average (for this exchange).
LHC Group, Inc. , a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI). The Home Health Services segment offers skilled nursing, medically oriented social services and physical, occupational, and speech therapy. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. Its Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand. The Facility-Based Services segment treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
